Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...

Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Scientists have unveiled a breakthrough imaging method that can capture the hidden details of events unfolding in trillionths ...

Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...

A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...

Marvell Technology’s acquisition of Polariton Technologies and its ties with POET Technologies ignited sharp gains in AI infrastructure stocks. The deal strengthens Marvell’s optical connectivity ...

Grifols (NASDAQ:GRFS) is one of the 10 Overlooked Growth Stocks to Buy Now. Grifols (NASDAQ:GRFS) is one of the overlooked ...

China’s newly released 15th five‑year plan offers a revealing insight into how Beijing understands future military power.

HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...

Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...